Individualizing Pharmacotherapy for African American Smokers

PHASE3CompletedINTERVENTIONAL
Enrollment

392

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

November 30, 2021

Study Completion Date

January 30, 2022

Conditions
Smoking Cessation
Interventions
DRUG

Nicotine patch

Participants will receive the 24-hour 21mg nicotine patch for up to 18 weeks of treatment.

DRUG

Varenicline Tartrate

VAR will be dispensed 0.5 mg once daily on Days 1-3, 0.5 mg twice daily on Days 4-7, and 1 mg twice daily from Day 8 through the end of treatment.

DRUG

Bupropion

BUP will be dispensed 150 mg once daily on Days 0-3 and then 150 mg twice daily from Day 4 through optimization or the end of treatment.

Trial Locations (1)

64130

Swope Health Central, Kansas City

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Kansas Medical Center

OTHER

NCT03897439 - Individualizing Pharmacotherapy for African American Smokers | Biotech Hunter | Biotech Hunter